A detailed history of Freemont Management S.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Freemont Management S.A. holds 10,000 shares of ABT stock, worth $1.18 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
10,000
Previous 6,820 46.63%
Holding current value
$1.18 Million
Previous $708,000 61.02%
% of portfolio
0.6%
Previous 0.4%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$100.07 - $118.13 $318,222 - $375,653
3,180 Added 46.63%
10,000 $1.14 Million
Q2 2024

Aug 06, 2024

SELL
$100.73 - $112.44 $3.34 Million - $3.73 Million
-33,200 Reduced 82.96%
6,820 $708,000
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $1.36 Million - $1.5 Million
-12,400 Reduced 23.66%
40,020 $4.55 Million
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $850,217 - $1.02 Million
-8,900 Reduced 14.51%
52,420 $5.08 Million
Q3 2022

Nov 07, 2022

SELL
$96.76 - $112.03 $145,140 - $168,045
-1,500 Reduced 2.39%
61,320 $5.93 Million
Q2 2022

Jul 29, 2022

SELL
$102.07 - $123.37 $326,624 - $394,784
-3,200 Reduced 4.85%
62,820 $6.83 Million
Q1 2022

May 06, 2022

BUY
$114.02 - $139.04 $7.53 Million - $9.18 Million
66,020 New
66,020 $7.81 Million
Q4 2021

Feb 07, 2022

SELL
$115.53 - $141.46 $11 Million - $13.5 Million
-95,420 Closed
0 $0
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $3.1 Million - $3.43 Million
-26,600 Reduced 21.8%
95,420 $11.3 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $2.86 Million - $3.36 Million
27,000 Added 28.42%
122,020 $14.1 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $9.98 Million - $10.9 Million
95,020 New
95,020 $10.4 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Freemont Management S.A. Portfolio

Follow Freemont Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freemont Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Freemont Management S.A. with notifications on news.